SCHEMBL26690149

SCHEMBL26690149

COc1ccc(CNC(=O)c2cc(C(C)=O)cc(Br)n2)c(OC)c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.57
TSHR P16473 2/20 0.57
NPSR1 Q6W5P4 2/20 0.57
TP53 P04637 5/20 0.50
LMNA P02545 3/20 0.50
MAOB P27338 1/20 0.50
TAS1R3 Q7RTX0 2/20 0.49
TAS1R1 Q7RTX1 2/20 0.49
GAA P10253 2/20 0.48
HPGD P15428 2/20 0.48
HTT P42858 2/20 0.48
PKM P14618 1/20 0.48
MAPT P10636 3/20 0.48
RXFP1 Q9HBX9 2/20 0.48
MEN1 O00255 1/20 0.46
MAPK1 P28482 1/20 0.46
KMT2A Q03164 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
HSD17B10 Q99714 1/20 0.46
ABCB1 P08183 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5212964 0.77 ALDH1A1 (0.65) ALDH1A1TSHRNPSR1TP53LMNA
SCHEMBL23985887 0.76 ALDH1A1 (0.60) ALDH1A1TSHRNPSR1TP53LMNA
SCHEMBL30451028 0.76 ALDH1A1 (0.60) ALDH1A1TSHRNPSR1TP53LMNA
SCHEMBL18336576 0.75 ALDH1A1 (0.55) ALDH1A1TSHRNPSR1TP53LMNA
SCHEMBL23115679 0.74 TSHR (0.55) ALDH1A1TSHRNPSR1TP53LMNA
SCHEMBL29766111 0.74 TSHR (0.55) ALDH1A1TSHRNPSR1TP53LMNA
SCHEMBL1145991 0.74 MAPK8 (0.57) ALDH1A1TSHRNPSR1GAAHPGD
SCHEMBL30856041 0.74 DGAT2 (0.61) ALDH1A1TSHRNPSR1TP53LMNA
SCHEMBL10141758 0.74 APLNR (0.65) ALDH1A1TSHRNPSR1TAS1R3TAS1R1
SCHEMBL8759043 0.74 HPGD (0.70) ALDH1A1TSHRNPSR1TP53TAS1R3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4526298-A1 PYRAZOLE DERIVATIVES AS STING AGONISTS F. Hoffmann-La Roche AG (CH) 2025-03-26 EP disclosed
US-20250074913-A1 PYRAZOLE DERIVATIVES AS STING AGONISTS HOFFMANN-LA ROCHE INC. (US) 2025-03-06 US disclosed
CN-119212989-A Pyrazole derivatives as STING agonists 豪夫迈·罗氏有限公司 2024-12-27 CN disclosed
WO-2023222644-A1 PYRAZOLE DERIVATIVES AS STING AGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2023-11-23 WO disclosed
WO-2023222644-A1 PYRAZOLE DERIVATIVES AS STING AGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2023-11-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250074913-A1 PYRAZOLE DERIVATIVES AS STING AGONISTS STING1, CGAS, MAVS ALDH1A1 4593/4885TSHR 1759/4885NPSR1 506/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.